Effect of Tofacitinib in Treating ANCA-associated Vasculitis

NCT04973033 · clinicaltrials.gov ↗

NA

Phase

COMPLETED

Status

10

Enrollment

OTHER

Sponsor class

Conditions

ANCA Associated Vasculitis
Drug Use
JAK-STAT Pathway Deregulation

Interventions

DRUG: Tofacitinib

Sponsor

Shanghai Zhongshan Hospital